World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
15227
World Ranking
3404
National Ranking
1580

Zuhair K. Ballas publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Zuhair K. Ballas sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 305 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Zuhair K. Ballas D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Zuhair K. Ballas sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Zuhair K. Ballas is affiliated with the University of Iowa in the United States. Their research primarily spans the field of Medicine, with over 100 publications in this area. Subfields of study include Immunology, Immunology and Allergy, Genetics, Surgery, and Pulmonary and Respiratory Medicine.

The scientist's research topics cover a range of health concerns, emphasizing allergic and respiratory conditions as well as genetic factors. Key topics include:

  • Allergic Rhinitis and Sensitization
  • Eosinophilic Esophagitis
  • Asthma and respiratory diseases
  • Pediatric health and respiratory diseases
  • Food Allergy and Anaphylaxis Research
  • IL-33, ST2, and ILC Pathways
  • Genetic Associations and Epidemiology

Frequent publication venues for Ballas include:

  • Journal of Allergy and Clinical Immunology
  • JAMA Network Open
  • Journal of Clinical Immunology
  • Annals of Allergy Asthma & Immunology
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature

Notable recent papers authored by Zuhair K. Ballas cover diverse subjects from genetic risk factors to clinical model development and therapeutic interventions. These papers include:

  • "Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis" (2020) published in Nature Genetics
  • "Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals" (2020) published in Critical Care Medicine
  • "Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes" (2021) published in Nature Communications
  • "Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma" (2021) published in Cancers
  • "Mendelian Randomization Analysis of Genetic Proxies of Thiazide Diuretics and the Reduction of Kidney Stone Risk" (2023) published in JAMA Network Open

Zuhair K. Ballas collaborates frequently with several researchers, indicating sustained scientific partnerships. Frequent co-authors include:

  • Philip S. Tsao
  • Marc E. Rothenberg
  • Iowa Deputy
  • David Huston
  • Leonard Philadelphia

Best Publications

  • Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells

    Anne Krug;Simon Rothenfusser;Veit Hornung;Bernd Jahrsdörfer

  • Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

    Z K Ballas;W L Rasmussen;A M Krieg

  • Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo

    Gunther Hartmann;Risini D. Weeratna;Zuhair K. Ballas;Zuhair K. Ballas;Paul Payette

  • Practice parameter for the diagnosis and management of primary immunodeficiency

    Francisco A. Bonilla;David A. Khan;Zuhair K. Ballas;Javier Chinen

  • Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    David J. Lederer;Scott C. Bell;Richard D. Branson;James D. Chalmers

  • Practice parameter for the diagnosis and management of primary immunodeficiency.

    Francisco A. Bonilla;I. Leonard Bernstein;David A. Khan;Zuhair K. Ballas

  • Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

    Jordan S. Orange;Mark Ballow;E. Richard Stiehm;Zuhair K. Ballas

  • Natural killer cells in human health and disease

    Jordan S. Orange;Zuhair K. Ballas

  • Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis

    Thomas B. Casale;William W. Busse;Joel N. Kline;Zuhair K. Ballas

  • Divergent Therapeutic and Immunologic Effects of Oligodeoxynucleotides with Distinct CpG Motifs

    Zuhair K. Ballas;Arthur M. Krieg;Arthur M. Krieg;Arthur M. Krieg;Thomas Warren;Wendy Rasmussen;Wendy Rasmussen

  • Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations

    Jordan S. Orange;Scott R. Brodeur;Ashish Jain;Francisco A. Bonilla

  • Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma

    James E. Wooldridge;Zuhair Ballas;Arthur M. Krieg;George J. Weiner

  • Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals.

    Daniel E. Leisman;Michael O. Harhay;David J. Lederer;David J. Lederer;Michael Abramson

  • The presentation and natural history of immunodeficiency caused by nuclear factor κB essential modulator mutation

    Jordan S Orange;Ashish Jain;Zuhair K Ballas;Lynda C Schneider

  • Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry

    Paul C. Mayor;Kevin H. Eng;Kelly L. Singel;Scott I. Abrams

  • Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma.

    Brian K. Link;Zuhair K. Ballas;Daniel Weisdorf;James E. Wooldridge

  • NK1.1+ thymocytes. Adult murine CD4-, CD8- thymocytes contain an NK1.1+, CD3+, CD5hi, CD44hi, TCR-V beta 8+ subset.

    Z K Ballas;W Rasmussen

  • Chronic ethanol consumption by mice results in activated splenic T cells

    Kejing Song;Ruth A. Coleman;Xiaoyan Zhu;Carol Alber

  • CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma

    Joel N. Kline;Arthur M. Krieg;Thomas J. Waldschmidt;Zuhair K. Ballas

  • Immune dysfunction in refractory sinusitis in a tertiary care setting.

    Lincoln Chee;Scott M. Graham;Daniel G. Carothers;Zuhair K. Ballas;Zuhair K. Ballas

Frequent Co-Authors

Arthur M. Krieg
Arthur M. Krieg University of Massachusetts Chan Medical School
Francisco A. Bonilla
Francisco A. Bonilla Boston Children's Hospital
George J. Weiner
George J. Weiner University of Iowa
Thomas J. Waldschmidt
Thomas J. Waldschmidt University of Iowa
Jordan S. Orange
Jordan S. Orange University of Pennsylvania
Cezmi A. Akdis
Cezmi A. Akdis University of Zurich
Thomas B. Casale
Thomas B. Casale University of South Florida
Charlotte Cunningham-Rundles
Charlotte Cunningham-Rundles Icahn School of Medicine at Mount Sinai
Mark Ballow
Mark Ballow University of South Florida
William W. Busse
William W. Busse University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open many doors. Many professionals choose accelerated routes to enter the workforce faster. Programs like accelerated np program offer a streamlined way for registered nurses to become nurse practitioners, combining clinical expertise with immunological knowledge.

If you are starting fresh, online rn programs for non nurses in florida provide a valuable bridge for non-nursing individuals to enter the field. These programs emphasize flexibility and accessibility, which can be critical when balancing other commitments.

Additionally, many prospective students look for the accelerated nursing programs that facilitate quick entry into nursing careers without compromising quality. These programs help to address workforce shortages while supporting diverse educational backgrounds.

For those interested in practical nursing roles, understanding which lpn programs are easiest to get into is essential. Licensed Practical Nurse (LPN) programs provide foundational skills that complement immunology studies and healthcare practice.

Best Scientists Citing Zuhair K. Ballas

Trending Scientists

Recently Published Articles